Relapsing-Remitting
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis (NCT04966338) | Cinnagen | 2019-08-19 |
| Adherence Trial With MS LifeLines ® Services (NCT01905527) | EMD Serono | 2013-07-01 |
| A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device (NCT01791244) | Merck KGaA, Darmstadt, Germany | 2013-02-28 |
| A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720 (NCT01578330) | Novartis Pharmaceuticals | 2012-10-01 |
| BEYOND Pilot Study (NCT00893217) | Bayer | 2002-11-01 |
Track Relapsing-Remitting automatically
Every clearance here is in the API, with alerts when new ones post.